Suppr超能文献

坦桑尼亚西米尤地区社区卫生工作者对严重急性营养不良儿童进行筛查和治疗的效果:一项准实验性试点研究。

Effectiveness of screening and treatment of children with severe acute malnutrition by community health workers in Simiyu region, Tanzania: a quasi-experimental pilot study.

机构信息

Maternal and Child Wellbeing Unit, African Population and Health Research Center, APHRC Campus, 2nd Floor, Manga Close, Off Kirawa Road, P.O. Box 10787, Nairobi, 00100, Kenya.

Epidemiology and Prevention Group, National Cancer Center, Tokyo, 104-0045, Japan.

出版信息

Sci Rep. 2021 Jan 27;11(1):2342. doi: 10.1038/s41598-021-81811-6.

Abstract

Health system constraints hamper treatment of children with severe acute malnutrition (SAM) in Tanzania. This non-inferiority quasi-experimental study in Bariadi (intervention) and Maswa (control) districts assessed the effectiveness, coverage, and cost-effectiveness of SAM treatment by community health workers (CHWs) compared with outpatient therapeutic care (OTC). We included 154 and 210 children aged 6-59 months with SAM [mid-upper arm circumference (MUAC) < 11.5 cm] without medical complications in the control and intervention districts, respectively. The primary treatment outcome was cure (MUAC ≥ 12.5 cm). We performed costing analysis from the provider's perspective. The probability of cure was higher in the intervention group (90.5%) than in the control group (75.3%); risk ratio (RR) 1.17; 95% CI 1.05, 1.31 and risk difference (RD) 0.13; 95% CI 0.04, 0.23. SAM treatment coverage was higher in the intervention area (80.9%) than in the control area (41.7%). The cost per child treated was US$146.50 in the intervention group and US$161.62 in the control group and that per child cured was US$161.77 and US$215.49 in the intervention and control groups, respectively. The additional costs per an additional child treated and cured were US$134.40 and US$130.92, respectively. Compared with OTC, treatment of children with uncomplicated SAM by CHWs was effective, increased treatment coverage and was cost-effective.

摘要

卫生系统的限制阻碍了坦桑尼亚严重急性营养不良(SAM)儿童的治疗。这项在 Bariadi(干预)和 Maswa(对照)地区进行的非劣效性准实验研究评估了社区卫生工作者(CHW)与门诊治疗(OTC)相比治疗 SAM 儿童的效果、覆盖率和成本效益。我们纳入了分别来自对照和干预地区的 154 名和 210 名年龄在 6-59 个月、无医疗并发症且中上臂围(MUAC)<11.5cm 的 SAM 患儿。主要治疗结局是治愈(MUAC≥12.5cm)。我们从提供者的角度进行了成本分析。干预组的治愈率(90.5%)高于对照组(75.3%);风险比(RR)为 1.17;95%CI 为 1.05-1.31,风险差异(RD)为 0.13;95%CI 为 0.04-0.23。干预地区的 SAM 治疗覆盖率(80.9%)高于对照地区(41.7%)。干预组每治疗一名儿童的成本为 146.50 美元,对照组为 161.62 美元,每治愈一名儿童的成本为 161.77 美元和 215.49 美元,干预组和对照组分别为 161.77 美元和 215.49 美元。每多治疗一名儿童和每多治愈一名儿童的额外成本分别为 134.40 美元和 130.92 美元。与 OTC 相比,CHW 治疗无并发症的 SAM 儿童是有效的,增加了治疗覆盖率,且具有成本效益。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验